Cart
Orders
Not available here
Product Overview
DR.LIPO+ is the 10mL-per-vial presentation in BNC Global's DR.LIPO+ family. Its declared main ingredients are Phosphatidylcholine (PPC) and Sodium Deoxycholate, and its package contains 10 vials. The family also includes DR.LIPO+ Prime and DR.LIPO+ V, with different labeled volumes per vial.
DR.LIPO+ Composition & Specifications
| Specification | DR.LIPO+ |
|---|---|
| Declared main ingredients | Phosphatidylcholine (PPC), Sodium Deoxycholate |
| Labeled volume per vial | 10mL |
| Package contents | 10 vials |
| Company-declared manufacturer | BNC Global |
| Company-declared manufacturing country | South Korea |
DR.LIPO+ Family Presentations
The three catalog lines have distinct labeled volumes per vial. Package volume does not establish ingredient concentration or relative strength.
| Catalog line | Labeled volume per vial | Package contents |
|---|---|---|
| DR.LIPO+ | 10mL | 10 vials |
| DR.LIPO+ Prime | 2mL | 10 vials |
| DR.LIPO+ V | 5 mL | 10 vials |
Product Label & Regulatory Notes
In a March 3, 2025 warning letter, the United States FDA identified the Dr. Lipo+ product marketed by the letter's recipient as an unapproved new drug and stated that no approved application was in effect for that product. That finding did not separately identify Prime or V, or specify an exact package SKU.